As one of the leading medical products companies, Singclean was invited to attend the 2019 annual medical device industry standard development and revision kick-off meeting held in Tianjin on 20, March to complete three verification schemes (half of the total) for revisions of standards for cross-linked sodium hyaluronate gel for plastic surgery.
Considering the revisions will speed up the development of the healthcare industry, Singclean puts the work in the first place and proposes the new schemes in a short time.
•All the schemes adopted are as follows:
Method for determining free sodium hyaluronate content
Method for determining swelling degree of cross-linked sodium hyaluronate gel
Method for determining cross-linked sodium hyaluronate gel protein content
-
singclean | 2019-05-24Singclean Medical shines at HOSPITALAR 2025: Deeply cultivate the Latin American medical market with R&D and intelligent manufacturingSao Paulo, Brazil —— Singclean Medical, a world-leading absorbable biomaterial company, appeared at HOSPITALAR 2025 in June 2025, bringing four major product lines including regenerative medical beauty, orthopedics, ophthalmology and surgical hemostasis, to systematically demonstrate its global strength driven by the dual core of "R&D + automation" to the Latin American market. As a benchmark exhibition in the Latin American medical industry, this HOSPITALAR brings together top companies from around the world. Singclean Medica has become one of the core concerns of professional audiences on site with its CE/NMPA/ANVISA multi-certified product matrix and localized cooperation results.
-
singclean | 2019-05-24Singclean Medical to Showcase Pioneering Aesthetic Solutions at HOSPITALAR 2025
-
singclean | 2019-05-24Singclean Medical·Singfiller Injection Technology Competition Concludes Successfully